Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WARTS-2 trial of monochloroacetic acid versus cryotherapy or combination therapy for hand and plantar warts
NL-OMON33146Phase 4Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of monochloroacetic acid and Salvax in verruca, common wart and plantar wart, sponsored by Leiden University Medical Center. Primary endpoint: Complete cure at 13 weeks. Started Sep 2009; status: active, not recruiting.
02
Drugs
monochloroacetic acidSalvax
03
Conditions
verrucacommon wartplantar wart
Beyond the preview
Go deeper on NL-OMON33146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33146.